Penn Medicine Study: Sorafenib Shows Success in Advanced Differentiated Thyroid Cancer Patients

The kidney and liver cancer drug sorafenib holds metastatic thyroid cancer at bay for nearly twice as long as a placebo, according to a new study from researchers in the Abramson Cancer Center at the University of Pennsylvania published in the journal Lancet. This is the first effective treatment for thyroid cancer patients who progress following standard treatments.

Steve Graff

Nicotine Withdrawal Weakens Brain Connections Tied to Self-Control Over Cigarette Cravings, Penn Study Finds

People who try to quit smoking often say that kicking the habit makes the voice inside telling them to light up even louder, but why people succumb to those cravings so often has never been fully understood.  Now, a new brain imaging study in this week’s JAMA Psychiatry from scientists in Penn Medicine and the National Institute on Drug Abuse (NIDA) Intramural Research Program sh

Steve Graff